×
戻る Agenda
Session 5, Track A: Unlocking the Future - How Advanced Therapies, Targeted Drugs and Companion Diagnostics Are Reshaping Therapeutics
Session Chair(s)
Maria Antonieta Roman
Head Regulatory Policy LaCan, Novartis, Mexico
Priscila De Lara Fagundes Esteves, RPH
Director Regulatory Affairs , PPD Clinical Research Services, Thermo Fisher Scientific, Brazil
Session 5, Track A: Unlocking the Future - How Advanced Therapies, Targeted Drugs and Companion Diagnostics Are Reshaping Therapeutics